Carotid intima-media thickness (CIMT) measured by ultrasound has been used as a marker of early subclinical atherosclerosis 1 and its values have been associated with a higher risk of cardiovascular events. 2 Traditional cardiovascular risk factors are associated with CIMT values, but much of the CIMT variance is not explained by major risk factors. 3 This residual unexplained variance highlights the importance of identifying other determinants of CIMT values.
maximum absolute difference in 3 within-visit measurements of DBP and CIMT in individuals without hypertension, but not among those under antihypertensive therapy.
The Brazilian Longitudinal Study of Adult Health (ELSABrasil) is a large multicenter cohort study conducted in 6 Brazilian cities. The aim of the present study are to investigate whether there is an association between CIMT values and BP variability in the ELSA-Brasil baseline assessment.
METHODS

Study design
ELSA-Brasil is a cohort study of 15,105 civil servants aged 35 to 74 years at baseline in 6 Brazilian cities. The study design, objectives, and cohort profile are described in detail in previous articles. 20, 21 The baseline assessment was a 7-hour examination (1 hour at the workplace and 6 hours at the corresponding ELSA-Brasil investigation site), comprising validated questionnaires, clinical, and laboratory exams. These assessments took place from August 2008 to December 2010. Approvals from the institutional review boards of all the sites were granted, all the participants signed informed consent forms and study protocol is in accordance with the Helsinki Declaration.
Study sample
Of the 10,943 ELSA-Brasil participants with valid CIMT values for both common carotid arteries, we excluded 415 (3.8%) who self-reported previous stroke, myocardial infarction, or revascularization, 2,720 (24.9%) using antihypertensive drugs and 21 (0.2%) with missing information about previous cardiovascular disease (CVD) or medication use. We also excluded 287 participants (2.6%) of self-declared Asian or Indigenous race (due to the low number of individuals in these groups), 97 (0.9%) for whom BP information was missing, and 188 (1.7%) for whom other information used in the statistical models was missing. As a result, our study sample comprised 7,215 participants (3,172 men and 4,043 women).
Study variables
BP measurements were taken using a validated oscillometric device (Omron HEM 705CPINT) 22 on multiple occasions, according to the ELSA-Brasil protocol. Ten BP readings were considered in analyses: 4 in the supine position, 3 in the sitting position, and 3 in the standing position. Additional data about these BP measurements are available in the Supplemental Data 1. In this article, BP variability was defined as the SD of these BP measurements.
CIMT protocol was published earlier 22, 23 and is detailed in the Supplemental Data 1. CIMT was measured in the outer wall of a 1 cm predefined carotid segment from 1 cm below the carotid bifurcation, during 3 cardiac cycles. All images were sent to the core reading center in São Paulo and underwent image quality assessment. We used the MIA software (Coralville, IA) to standardize the reading and interpretation of valid carotid scans. In this paper, we defined CIMT as the average between the mean left and mean right CIMT values. Abnormal CIMT values were defined as those above the 75 th percentile for a given age, sex and race, based on the ELSABrasil distribution. 23 Family history of premature CVD (diagnosis of myocardial infarction, stroke, revascularization, or sudden death in a first-degree relative before the age of 60 years), smoking status, and race were self-reported. Body mass index was calculated as weight (in kilograms) divided by the square of height (in meters). Diabetes was defined as having a medical history of diabetes, use of medications to treat diabetes, fasting glucose ≥126 mg/dl, glycated hemoglobin (HbA1C) levels ≥6.5% or a 2-hour oral glucose tolerance test ≥200 mg/dl. Dyslipidemia was defined as use of lipid-lowering medication or a LDL cholesterol level ≥130 mg/dl.
Statistical analysis
Descriptive statistics are presented as means, SDs, absolute counts, and proportions, whenever appropriate. To evaluate the association between BP variability and CIMT, we performed a 2-step analysis, detailed in the Supplemental Data 1. Briefly, we first linearly regressed the CIMT values on main and all-order interaction effects of the variables age, sex, race, body mass index, diabetes diagnosis, dyslipidemia diagnosis, family history of premature CVD, smoking status, and ELSA-Brasil site ( Figure 1 ). We defined a new variable (residual CIMT) calculating the residuals (observed minus predicted CIMT values) from this linear model. With this strategy, residual CIMT represents the part of CIMT values that were not explained by the variables above.
In a second step of the analysis, we performed a Partial Least Squares Path Modeling (PLS-PM) 24 to investigate if the BP measurements of central tendency and variability were significantly associated with residual CIMT, for the whole sample, and for men and women. This technique includes latent variables, which may summarize highly correlated variables, as is the case of multiple BP measurements in our study. To avoid multicollinearity and inconsistent results, the analysis was performed separately for both SBP and DBP measurements. P values were adjusted for multiple comparisons using the Holm-Bonferroni procedure. We also applied a permutation test to assess potential differences in the effect of BP variability on residual CIMT according to After observing a positive association between SBP variability and CIMT, we performed post-hoc sensitivity analyses. We analyzed 3 different subsamples: (i) participants with average SBP <140 mm Hg and average DBP <90 mm Hg (2,640 men and 3,747 women); (ii) participants with all SBP measurements <140 mm Hg and all DBP measurements <90 mm Hg (1,616 men and 2,876 women); and (iii) participants with average SBP ≥140 mm Hg or average DBP ≥90 mm Hg (532 men and 296 women). The analyses were performed using R software version 3.2.1 (Vienna, Austria) 25 and the plspm package. 26 The significance level was set at 0.05. Table 1 summarizes the characteristics of the study sample. In the sample, considering all 10 BP measurements, 658 (9.1%) had mean SBP ≥140 mm Hg, 531 (7.4%) had mean DBP ≥90 mm Hg, and 1,598 (22.1%) had abnormal CIMT values (above the 75 th percentile for their age, sex, and race).
RESULTS
Linear regression models included age, race, body mass index, diabetes and dyslipidemia diagnoses, family history of premature CVD, smoking status, site effect, and their interactions ( Figure 1 ). These models yielded R 2 values of 0.5242 for the whole sample, 0.5238 for men and 0.5023 for women. Figure 2 shows the results of the PLS-PM analysis using SBP values for all individuals, men and women, respectively. The latent variable representing SBP central tendency was significantly associated with residual CIMT in both men and women (P < 0.001 for all comparisons). SBP variability in the ELSA-Brasil baseline was significantly associated with residual CIMT in the models including the entire sample (P < 0.001), and when restricted to women (P = 0.007). When analyzing models restricted to men, the association between SBP variability and residual CIMT lost significance (P = 0.09). The results of the permutation test, however, showed that path coefficients (PCs) for this association were not significantly different between men and women (nonadjusted P = 0.68; Holm-adjusted P = 0.995), suggesting that this loss of significance may be mainly due to the smaller number of men in the sample.
Although significantly associated with residual CIMT, SBP explained little of the variance of the residual CIMT in this cross-sectional analysis. For all individuals, 2.25% (95% confidence interval: 1.63-3.01%) of residual CIMT could When we analyzed the association between DBP and residual CIMT, we also found that the latent variable representing the DBP central tendency was significantly associated with residual CIMT (P < 0.001 for all comparisons). However, DBP variability was not significantly associated with residual CIMT in models with all individuals (P = 1.00), or restricted to men (P = 0.94) or women (P = 1.00).
Supplemental Figures 1 to 3 show the results of the PLS-PM for sensitivity analyses. SBP variability in participants with average SBP <140 mm Hg and average DBP <90 mm Hg was significantly associated with residual CIMT in models with all participants (P < 0.001) and in women (P = 0.002), but not in models restricted to men (P = 0.26). Similarly, SBP variability in participants with all SBP and DBP measurements within the normal range was significantly associated with residual CIMT in models with all participants (P = 0.006). However, statistical significance vanished after sex stratification (P = 0.10 and P = 0.13 for women and men, respectively). SBP variability was not significantly associated with residual CIMT in participants with average SBP ≥140 mm Hg or average DBP ≥90 mm Hg. 
DISCUSSION
In this large sample of individuals without CVD or antihypertensive use, we found small but significant associations between SBP variability during the ELSA-Brasil onsite baseline protocol and CIMT values. This was additive to the association between SBP central tendency and CIMT, and after excluding the proportion of CIMT explainable by major confounders and their interactions. PCs for this association were not significantly different according to sex.
Although we found that small proportions of residual CIMT variance were explained by BP values, this should not undermine the fact that isolated or average BP measurements have been consistently associated with CIMT in ELSA-Brasil 3,27 and other samples. [28] [29] [30] It is reasonable to consider that in our 2-step strategy, a significant part of the association between BP and CIMT vanished when the effects of confounders were minimized, due to the correlation between these confounders and BP. High BP levels may induce shear stress and consequent endothelial dysfunction, resulting in accelerated atherosclerosis. 31 The association between BP and CVD seems to be nonlinear, starting at a SBP of 115 mm Hg. 32 If this occurs, periods of lower BP may not be sufficient to compensate for the risk associated with the periods of higher BP in individuals with high BP variability. Therefore, we can hypothesize that individuals with high BP variability may have more accelerated atherosclerosis compared to individuals with lower BP variability and similar average BP. In addition, even small associations at individual level may be relevant at population level. Although we focused on CIMT, which is a surrogate for clinical disease, 2 our results suggest that, at population level, BP variability play a role in the development of atherosclerotic disease, as myocardial infarction and ischemic stroke. We did not find, however, a significant association between BP variability and CIMT in individuals with average SBP ≥140 mm Hg or average DBP ≥90 mm Hg. This may be due to the smaller subsample size. As we excluded individuals using antihypertensive medication from all analyses, individuals with abnormal BP levels are a small proportion (11.5%) of our study sample. In addition, it is possible that the higher BP load caused by higher average BP supersedes the effect of high BP variability in individuals with sustained hypertension. On the other hand, we must notice that only untreated individuals were included, and results for this group may not be extensible to all individuals with hypertension.
As in the present study, other authors have explored the association between BP variability and CIMT values. We note, however, that populations, BP variability definitions, and CIMT measurement protocols are heterogeneous across studies. It is important to note that BP variability measured over short periods of time and BP variability estimated over 24 hours or longer may not reflect the same phenomena. For example, BP variability calculated from long periods may be influenced by the circadian rhythm, 33 changes in diet pattern, 34 or in arterial stiffness. 35 These factors, however, may have less influence on within-visit or beat-to-beat BP variability. Different BP variability definitions may yield heterogeneous associations with CIMT values, as observed by Manios et al. 15 In that article, the authors evaluated cross-sectional data from 85 individuals without antihypertensive treatment and found that beat-to-beat BP variability over three 5-minute BP recordings, but not BP variability estimates from 24-hour ABPM, were associated with mean CIMT values.
Mancia et al. 9 analyzed baseline data from 1,663 subjects with hypertension from the European Lacidipine Study on Atherosclerosis and found a positive association between composite measurements of CIMT (in 12 carotid sites) and 24-hour ABPM SBP variability. Kim et al. 10 analyzed data from 364 subjects with coronary artery disease from the PREVENT trial, and found a positive association between multiple-visit SBP variability and maximal CIMT. Song et al. 11 analyzed 356 patients with hypertension from the Chinese Hypertension Intervention Efficacy study over a 4-year follow-up. They found that multiple-visit SBP variability was positively associated with maximal CIMT values. It is important to note that these positive results were described in subsidiary analyses of clinical trials. Intervention studies typically have inclusion and exclusion criteria that result in less comparability to a general population. Our results, from a larger and less selected sample, support an extension of these findings, including to those not under antihypertensive medication.
Other authors verified the association between BP variability and CIMT in observational settings. Consistently with our findings, home-based 7-day 17 and 1-year multiple visit 18 SBP variability has been associated to maximal CIMT. Other authors have also demonstrated that multiple-visit BP variability is positively associated with cardiovascular events. 36, 37 On the other hand, Tian et al. 16 analyzed 24-hour ABPM values from 150 individuals and found heterogeneous associations between BP variability and mean CIMT values. The association was more evident for SBP than for DBP, and was significant in men, but not in women (in contrast to our results), and in younger (≤55 years old) individuals. Those authors used an alternate definition for BP variability; the average real variability. 38 The most commonly used SD is based on a sum of squared differences to the mean. The average real variability is based on the absolute differences between sequential measurements, so the order (in time) the measurements are obtained influence the results. This may yield considerable differences in BP variability measurements. Another index based on ordered BP measurements is proposed by Zakopoulos et al., 39 the time rate of BP variation, which is influenced by the elapsed time between measurements. Studying 24-hour ABPM data from 539 individuals, they found that a 0.1 mm Hg/min increase in the 24-hour rate of SBP variation was associated to a significant increase of 0.029 mm in mean CIMT.
Estimates of BP variability, in most studies, are derived from 24-hour ABPM data or longer observations. In our study, we show that BP measurements obtained over short periods may also be associated with CIMT values. Although the study of shorter periods is less frequent, other authors have adopted this strategy. In the aforementioned study by Li et al., 19 the authors observed that the maximum difference during 3 within-visit DBP measurements was positively associated with higher CIMT values in individuals without hypertension. No significant association was observed between the maximum difference in SBP measurements and CIMT values, although a nonsignificant trend was found (P = 0.18).
Our study has some strengths. We studied the association between BP variability and CIMT in a very large sample of individuals free of CVD or antihypertensive use, which may have reduced the reverse causation effects. We used a computer-aided protocol for the CIMT measurement, with strict quality control. BP measurements used automated devices and were obtained in varying positions, which may mimic quotidian variations in BP. Some limitations may be pointed as well. We did not perform a complete reproducibility study for CIMT measurements in the ELSA-Brasil study; therefore, we do not have measurements of interobserver and intraobserver variability. However, we applied strict image quality control, and reading of all images was centralized with computer-aided measurements, minimizing operator influence. CIMT may be influenced by phenomena other than atherosclerosis as, for example, medial hypertrophy. 40 Therefore, it may be a weaker marker of target organ damage compared with other strategies (for example, coronary artery calcium scans). Our cross-sectional design does not allow us to infer causality. Although BP measurements were performed within a 6-hour evaluation in the ELSA-Brasil investigation centers, the order and timing of BP acquisitions were not the same for all participants in all sites. This impairs the use of time-based BP variability measurements. However, it is important to note that, as in our study, SD (which is not a time-based BP variability definition) was used in most studies.
In conclusion, in this large sample of individuals without CVD and not using antihypertensive medication, we found small but significant positive associations between SBP variability (within a 6-hour evaluation) and CIMT values. This was additive to the association between SBP central tendency and CIMT values, supporting a role for high short-term SBP variability in atherosclerosis.
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